Search

A SPIRIT THAT IS NOT AFRAID

Search
Home
Coronavirus
Community
Sports
Campus
Lifestyle
Opinion
Blogs
Video
Photo
Audio
About Us
Classifieds
Advertise

Auburn's News Source

The Auburn Plainsman

Sunday, June 26, 2022 Print Edition

Send a News Tip
Donate
  • Plainsman's Choice
  • Community
  • Campus
  • Sports
  • Lifestyle
  • Opinion
  • Video
  • Photo
  • About Us
  • Classifieds
  • Advertise
  • Community
  • Campus
  • Sports
  • Lifestyle
  • Opinion
  • Video
  • Photo
  • Audio
  • Blogs
  • About Us
  • Classifieds
  • Advertise

6/13/2015, 7:19am

University launches cancer research partnership with Nuovo Biologics

By Maria McIlwain | News Editor

Share

  • Share
  • Tweet
  • Mail
  • Print

Auburn researchers and Nuovo Biologics, based out of Davie, Florida, have teamed up to research a new cancer therapy.

According to Bruce Smith, research professor, the therapy is in the form of a peptide, a biological molecule. He said the peptide originated from a component of cobra venom, however it is non-toxic.

Bruce said they want to find a way to make the peptide in a laboratory or a factory, however, so it will be consistent.

Bruce said the current study is focusing on the effect of  the peptide on oral melanoma in dogs. He said the cancer is common in both dogs and people.

:"If [the therapy] works in dogs, there's the possibility that it also might work in people," Bruce said. "We call it a one medicine approach, where we're thinking about both at the same time."

Bruce said the ultimate goal would to try the treatment in people if it is successful in people. He said they could broaden it to test the effect of the drug on other cancers, but it would still be considered a success if it only worked on one type of cancer.

"We think about cancer as a disease, and that's a mistake because each cancer type is different, and even if we talk about one type of cancer, it's really a mistake to think about it as a uniform single thing because each person or each individual animal's cancer is different," Bruce said. "It's great to think about a magic bullet that will kill all cancers, but it's not going to work that way."


Sign up for our newsletter

Get The Plainsman straight to your inbox.


Bruce said they want to improve cancer treatments.

"We want to do better than we're doing now," Bruce said.

Bruce said they could use the therapy on clients who come to Auburn veterinary hospital.

Bruce said Nuovo sought out Auburn researchers to collaborate on the project and it has been in the works for approximately three years.

"Now the collaboration, the interaction is real," Bruce said.

Rusty Arnold, associate professor of drug discovery and development, said he and his team are working to find the most effective dose of the drug. He said he is also trying to determine the best way to administer the drug, and said he is looking at intravenous administration.

"It's kind of an exciting time," Arnold said.

Arnold said they can take lessons from animal trials and apply them to treating humans.

"Everything we learn from these products to help treat dogs ... we can use them to treat humans," Arnold said.

Annette Smith, professor of clinical sciences, said they are looking at how the drug will affect or control tumor spread without surgery. She said she wants the treatment to help keep pets in remission.

"A cure is the Holy Grail," Annette said.

Bruce said dogs from all over the country to participate in the trials.

"People are very interested in doing everything they can for their pets, because they're members of the family," Bruce said.

Share

Do you like this story? The Plainsman doesn't accept money from tuition or student fees, and we don't charge a subscription fee. But you can donate to support The Plainsman.

Support The Plainsman

Maria McIlwain | News Editor



Related Stories

After the primary election in May, the Republican primary winner for the District 27 senate race could be decided by a coin toss. 

Republican primary winner for state Senate to be decided by lot

By Destini Ambus | Editor-in-Chief

PERIOD members run in the Period Proud 5k. 

LETTER TO THE EDITOR | Period poverty demographics and accessibility

By Maris Laney, Landry Tharp and Maddie Gutkowski | Auburn Students

While locations on-campus do sell menstrual hygiene products, those who started the petition said these products need to be offered for free to help alleviate period poverty on college campuses. 

LETTER TO THE EDITOR | Bring menstrual equity to Alabama

By Reagan Moss | Auburn Student and Landry Tharp


Share and discuss “University launches cancer research partnership with Nuovo Biologics” on social media.

 facebook  twitter

Editor's Picks


6/26/2022, 3:05pm

LETTER TO THE EDITOR | Alabama student activists to hold rally against new prisons

By Taylor Gusler | Auburn student

6/23/2022, 9:45pm

More history made for Auburn hoops as Timberwolves snag Kessler in NBA Draft


6/23/2022, 7:42pm

Jabari Smith selected third overall by the Houston Rockets


6/20/2022, 6:53pm

Auburn stays alive in College World Series behind Foster's big swing


Virtual Print Edition


Plainsman Podcasts

The Auburn Plainsman To Homepage
  • About
  • Contact
  • Corrections
  • Archives
  • Advertise
  • Letters

All Rights Reserved

© Copyright 2022 The Auburn Plainsman

Powered by Solutions by The State News.